Literature DB >> 2617184

Classification of inflammatory bowel disease.

J E Lennard-Jones1.   

Abstract

Infection, ischaemia, physical damage, or specific immunologic sensitivity should be excluded as far as possible before a diagnosis of non-specific inflammatory bowel disease is made. Non-specific inflammations can be subdivided on the basis of macroscopic and microscopic anatomical criteria. Macroscopic structural abnormalities can be recognized by clinical examination, endoscopy, radiology, and inspection of an operation specimen. These complementary methods of data collection combine with microscopic examinations of tissue to separate disorders that differ in prognosis and possible response to treatment. Anatomic classifications do not necessarily imply differences in aetiology and may change with advances in knowledge.

Entities:  

Mesh:

Year:  1989        PMID: 2617184     DOI: 10.3109/00365528909091339

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  493 in total

1.  Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease.

Authors:  J Hampe; N J Lynch; S Daniels; S Bridger; A J Macpherson; P Stokkers; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Hyperhomocysteinemia in Greek patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Dilaveraki; I G Vlachonikolis; E Vardas; G Vrentzos; E Ganotakis; I A Mouzas; A Gravanis; D Emmanouel; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

3.  Genetic analyses of chromosome 12 loci in Crohn's disease.

Authors:  S Lesage; H Zouali; J F Colombel; J Belaiche; J P Cézard; C Tysk; S Almer; M Gassull; V Binder; M Chamaillard; I Le Gall; G Thomas; J P Hugot
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

4.  Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p.

Authors:  Jochen Hampe; Henning Frenzel; Muddassar M Mirza; Peter J P Croucher; Andrew Cuthbert; Silvia Mascheretti; Klaus Huse; Matthias Platzer; Stephen Bridger; Birgit Meyer; Peter Nürnberg; Pieter Stokkers; Michael Krawczak; Christopher G Mathew; Mark Curran; Stefan Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases.

Authors:  L Kazemi-Shirazi; C H Gasche; S Natter; A Gangl; J Smolen; S Spitzauer; P Valent; D Kraft; R Valenta
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

6.  CARD4/NOD1 is not involved in inflammatory bowel disease.

Authors:  H Zouali; S Lesage; F Merlin; J-P Cézard; J-F Colombel; J Belaiche; S Almer; C Tysk; C O'Morain; M Gassull; S Christensen; Y Finkel; R Modigliani; C Gower-Rousseau; J Macry; M Chamaillard; G Thomas; J-P Hugot
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

7.  CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Authors:  Yu-Hwa Huang; Chen Zhu; Yasuyuki Kondo; Ana C Anderson; Amit Gandhi; Andrew Russell; Stephanie K Dougan; Britt-Sabina Petersen; Espen Melum; Thomas Pertel; Kiera L Clayton; Monika Raab; Qiang Chen; Nicole Beauchemin; Paul J Yazaki; Michal Pyzik; Mario A Ostrowski; Jonathan N Glickman; Christopher E Rudd; Hidde L Ploegh; Andre Franke; Gregory A Petsko; Vijay K Kuchroo; Richard S Blumberg
Journal:  Nature       Date:  2014-10-26       Impact factor: 49.962

8.  Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease.

Authors:  María Jesús Martínez; Tomás Ripollés; Jose María Paredes; Eduardo Moreno-Osset; Juan Manuel Pazos; Esther Blanc
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

9.  Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.

Authors:  Zaid Bilgrami; Ameer Abutaleb; Kenechukwu Chudy-Onwugaje; Patricia Langenberg; Miguel Regueiro; David A Schwartz; J Kathleen Tracy; Leyla Ghazi; Seema A Patil; Sandra M Quezada; Katharine M Russman; Charlene C Quinn; Guruprasad Jambaulikar; Dawn B Beaulieu; Sara Horst; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

10.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors:  Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal:  Nature       Date:  2012-11-08       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.